Progress in the study of aging marker criteria in human populations

The use of human aging markers, which are physiological, biochemical and molecular indicators of structural or functional degeneration associated with aging, is the fundamental basis of individualized aging assessments. Identifying methods for selecting markers has become a primary and vital aspect...

Full description

Bibliographic Details
Main Authors: Yan He, Zhe Li, Yue Niu, Yuting Duan, Qian Wang, Xiaomin Liu, Zheyi Dong, Ying Zheng, Yizhi Chen, Yong Wang, Delong Zhao, Xuefeng Sun, Guangyan Cai, Zhe Feng, Weiguang Zhang, Xiangmei Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2024.1305303/full
_version_ 1827375666763399168
author Yan He
Yan He
Zhe Li
Yue Niu
Yuting Duan
Qian Wang
Xiaomin Liu
Zheyi Dong
Ying Zheng
Yizhi Chen
Yizhi Chen
Yong Wang
Delong Zhao
Xuefeng Sun
Guangyan Cai
Zhe Feng
Weiguang Zhang
Xiangmei Chen
Xiangmei Chen
author_facet Yan He
Yan He
Zhe Li
Yue Niu
Yuting Duan
Qian Wang
Xiaomin Liu
Zheyi Dong
Ying Zheng
Yizhi Chen
Yizhi Chen
Yong Wang
Delong Zhao
Xuefeng Sun
Guangyan Cai
Zhe Feng
Weiguang Zhang
Xiangmei Chen
Xiangmei Chen
author_sort Yan He
collection DOAJ
description The use of human aging markers, which are physiological, biochemical and molecular indicators of structural or functional degeneration associated with aging, is the fundamental basis of individualized aging assessments. Identifying methods for selecting markers has become a primary and vital aspect of aging research. However, there is no clear consensus or uniform principle on the criteria for screening aging markers. Therefore, we combine previous research from our center and summarize the criteria for screening aging markers in previous population studies, which are discussed in three aspects: functional perspective, operational implementation perspective and methodological perspective. Finally, an evaluation framework has been established, and the criteria are categorized into three levels based on their importance, which can help assess the extent to which a candidate biomarker may be feasible, valid, and useful for a specific use context.
first_indexed 2024-03-08T11:55:18Z
format Article
id doaj.art-4e5b9d791a7740f59928b2e90e439109
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-03-08T11:55:18Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-4e5b9d791a7740f59928b2e90e4391092024-01-24T04:36:34ZengFrontiers Media S.A.Frontiers in Public Health2296-25652024-01-011210.3389/fpubh.2024.13053031305303Progress in the study of aging marker criteria in human populationsYan He0Yan He1Zhe Li2Yue Niu3Yuting Duan4Qian Wang5Xiaomin Liu6Zheyi Dong7Ying Zheng8Yizhi Chen9Yizhi Chen10Yong Wang11Delong Zhao12Xuefeng Sun13Guangyan Cai14Zhe Feng15Weiguang Zhang16Xiangmei Chen17Xiangmei Chen18Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, ChinaThe First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, ChinaDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, ChinaDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, ChinaDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, ChinaDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, ChinaDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, ChinaDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, ChinaDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, ChinaDepartment of Nephrology, Hainan Hospital of Chinese PLA General Hospital, Hainan Province Academician Team Innovation Center, Sanya, ChinaDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, ChinaDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, ChinaDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, ChinaDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, ChinaDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, ChinaDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, ChinaChengdu University of Traditional Chinese Medicine, Chengdu, ChinaDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, ChinaThe use of human aging markers, which are physiological, biochemical and molecular indicators of structural or functional degeneration associated with aging, is the fundamental basis of individualized aging assessments. Identifying methods for selecting markers has become a primary and vital aspect of aging research. However, there is no clear consensus or uniform principle on the criteria for screening aging markers. Therefore, we combine previous research from our center and summarize the criteria for screening aging markers in previous population studies, which are discussed in three aspects: functional perspective, operational implementation perspective and methodological perspective. Finally, an evaluation framework has been established, and the criteria are categorized into three levels based on their importance, which can help assess the extent to which a candidate biomarker may be feasible, valid, and useful for a specific use context.https://www.frontiersin.org/articles/10.3389/fpubh.2024.1305303/fullmarkeragingaging markershumanbiological agechronological age
spellingShingle Yan He
Yan He
Zhe Li
Yue Niu
Yuting Duan
Qian Wang
Xiaomin Liu
Zheyi Dong
Ying Zheng
Yizhi Chen
Yizhi Chen
Yong Wang
Delong Zhao
Xuefeng Sun
Guangyan Cai
Zhe Feng
Weiguang Zhang
Xiangmei Chen
Xiangmei Chen
Progress in the study of aging marker criteria in human populations
Frontiers in Public Health
marker
aging
aging markers
human
biological age
chronological age
title Progress in the study of aging marker criteria in human populations
title_full Progress in the study of aging marker criteria in human populations
title_fullStr Progress in the study of aging marker criteria in human populations
title_full_unstemmed Progress in the study of aging marker criteria in human populations
title_short Progress in the study of aging marker criteria in human populations
title_sort progress in the study of aging marker criteria in human populations
topic marker
aging
aging markers
human
biological age
chronological age
url https://www.frontiersin.org/articles/10.3389/fpubh.2024.1305303/full
work_keys_str_mv AT yanhe progressinthestudyofagingmarkercriteriainhumanpopulations
AT yanhe progressinthestudyofagingmarkercriteriainhumanpopulations
AT zheli progressinthestudyofagingmarkercriteriainhumanpopulations
AT yueniu progressinthestudyofagingmarkercriteriainhumanpopulations
AT yutingduan progressinthestudyofagingmarkercriteriainhumanpopulations
AT qianwang progressinthestudyofagingmarkercriteriainhumanpopulations
AT xiaominliu progressinthestudyofagingmarkercriteriainhumanpopulations
AT zheyidong progressinthestudyofagingmarkercriteriainhumanpopulations
AT yingzheng progressinthestudyofagingmarkercriteriainhumanpopulations
AT yizhichen progressinthestudyofagingmarkercriteriainhumanpopulations
AT yizhichen progressinthestudyofagingmarkercriteriainhumanpopulations
AT yongwang progressinthestudyofagingmarkercriteriainhumanpopulations
AT delongzhao progressinthestudyofagingmarkercriteriainhumanpopulations
AT xuefengsun progressinthestudyofagingmarkercriteriainhumanpopulations
AT guangyancai progressinthestudyofagingmarkercriteriainhumanpopulations
AT zhefeng progressinthestudyofagingmarkercriteriainhumanpopulations
AT weiguangzhang progressinthestudyofagingmarkercriteriainhumanpopulations
AT xiangmeichen progressinthestudyofagingmarkercriteriainhumanpopulations
AT xiangmeichen progressinthestudyofagingmarkercriteriainhumanpopulations